Bacteriophages : Alternatives to Antibiotics and Beyond

There is talk of an upcoming antibiotic armageddon, with untreatable post-operative infections, and similarly untreatable complications after chemotherapy. Indeed, the now famous “O’Neill Report” (https://amr-review.org/) suggests that, by 2050, more people might die from antibiotic-resistant bacter...

Full description

Saved in:
Bibliographic Details
HerausgeberIn:
Sonstige:
Year of Publication:2020
Language:English
Physical Description:1 electronic resource (390 p.)
Tags: Add Tag
No Tags, Be the first to tag this record!
id 993546336004498
ctrlnum (CKB)5400000000045038
(oapen)https://directory.doabooks.org/handle/20.500.12854/69333
(EXLCZ)995400000000045038
collection bib_alma
record_format marc
spelling Suárez, Pilar García edt
Bacteriophages Alternatives to Antibiotics and Beyond
Bacteriophages
Basel, Switzerland MDPI - Multidisciplinary Digital Publishing Institute 2020
1 electronic resource (390 p.)
text txt rdacontent
computer c rdamedia
online resource cr rdacarrier
There is talk of an upcoming antibiotic armageddon, with untreatable post-operative infections, and similarly untreatable complications after chemotherapy. Indeed, the now famous “O’Neill Report” (https://amr-review.org/) suggests that, by 2050, more people might die from antibiotic-resistant bacterial infections than from cancer. While we are still learning all the subtle drivers of antibiotic resistance, it seems increasingly clear that we need to take a “one health” approach, curtailing the use of antibiotics in both human and veterinary medicine. However, there are no new classes of antibiotics on our horizon. Maybe something that has been around “forever” can come to our rescue—bacteriophages! Nevertheless, it is also necessary to do things differently, and use these new antimicrobials appropriately. Therefore, an in-depth study of bacteriophage biology and case-by-case applications might be required. Whilst by no means comprehensive, this book does cover some of the many topics related to bacteriophages as antimicrobials, including their use in human therapy and aquaculture. It also explores the potential use of phage endolysins as substitutes of antibiotics in two sectors where there is an urgent need—human therapy and the agro-food industry. Last but not least, there is an excellent perspective article on phage therapy implementation.
English
Medicine bicssc
bacteriophages
dairy industry
pathogens
lactic acid bacteria
fermentation failure
biofilms
antimicrobial resistance
antimicrobials
lysins
horizontal gene transfer, transduction
biofilm
phage therapy
resistance
bacteriophage
models
agent based
mass action
bacterial phage resistance
regression modeling
MRSA
Clostridium difficile
Clostridium difficile infection
microbiome
in vitro fermentation model
marine vibrios
biological control
aquaculture
interactions
vibriosis
Aeromonas hydrophila
Motile Aeromonas Septicemia
MAS
multiple-antibiotic-resistance
striped catfish (Pangasianodon hypophthalmus)
endolysin
antibiotics
one health
protein engineering
Aeromonas salmonicida
furunculosis
phage-resistant mutants
proteins
infrared spectroscopy
lysin
lytic enzyme
peptidoglycan hydrolase
antimicrobial
antibacterial
antibiotic resistance
bacteriophage therapy
Nagoya Protocol
CRISPR CAS
phage isolation
phage resistance
Staphylococcus
Kayvirus
Vibrio anguillarum
fish larvae
challenge trials
phage display
enzybiotics
diabetic foot ulcer
osteomyelitis
Staphylococcus aureus
Antibiotic-resistant bacteria
lysogenic conversion
prophage induction
read recruitment
shiga toxin
American Foulbrood
phage
Paenibacillus larvae
Brevibacillus laterosporus
treatment
safety
bystander phage therapy
Mycobacterium smegmatis
mycobacteriophages
directed evolution
PlyC CHAP
protein net charge
CBD-independent
FoldX
STEC-specific bacteriophage
whole genome sequencing
STEC O145 strains
antimicrobial agent
Pseudomonas aeruginosa
dual-species
antibiotic
synergy
simultaneous
sequential
microbiome therapy
evolution
3-03943-404-7
3-03943-405-5
Fernández, Lucía edt
Suárez, Pilar García oth
Fernández, Lucía oth
language English
format eBook
author2 Fernández, Lucía
Suárez, Pilar García
Fernández, Lucía
author_facet Fernández, Lucía
Suárez, Pilar García
Fernández, Lucía
author2_variant p g s pg pgs
l f lf
author2_role HerausgeberIn
Sonstige
Sonstige
title Bacteriophages Alternatives to Antibiotics and Beyond
spellingShingle Bacteriophages Alternatives to Antibiotics and Beyond
title_sub Alternatives to Antibiotics and Beyond
title_full Bacteriophages Alternatives to Antibiotics and Beyond
title_fullStr Bacteriophages Alternatives to Antibiotics and Beyond
title_full_unstemmed Bacteriophages Alternatives to Antibiotics and Beyond
title_auth Bacteriophages Alternatives to Antibiotics and Beyond
title_alt Bacteriophages
title_new Bacteriophages
title_sort bacteriophages alternatives to antibiotics and beyond
publisher MDPI - Multidisciplinary Digital Publishing Institute
publishDate 2020
physical 1 electronic resource (390 p.)
isbn 3-03943-404-7
3-03943-405-5
illustrated Not Illustrated
work_keys_str_mv AT suarezpilargarcia bacteriophagesalternativestoantibioticsandbeyond
AT fernandezlucia bacteriophagesalternativestoantibioticsandbeyond
AT suarezpilargarcia bacteriophages
AT fernandezlucia bacteriophages
status_str n
ids_txt_mv (CKB)5400000000045038
(oapen)https://directory.doabooks.org/handle/20.500.12854/69333
(EXLCZ)995400000000045038
carrierType_str_mv cr
is_hierarchy_title Bacteriophages Alternatives to Antibiotics and Beyond
author2_original_writing_str_mv noLinkedField
noLinkedField
noLinkedField
_version_ 1796648777885417472
fullrecord <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>05600nam-a2201477z--4500</leader><controlfield tag="001">993546336004498</controlfield><controlfield tag="005">20240122104458.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr|mn|---annan</controlfield><controlfield tag="008">202105s2020 xx |||||o ||| 0|eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)5400000000045038</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(oapen)https://directory.doabooks.org/handle/20.500.12854/69333</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)995400000000045038</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Suárez, Pilar García</subfield><subfield code="4">edt</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Bacteriophages</subfield><subfield code="b">Alternatives to Antibiotics and Beyond</subfield></datafield><datafield tag="246" ind1=" " ind2=" "><subfield code="a">Bacteriophages</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="a">Basel, Switzerland</subfield><subfield code="b">MDPI - Multidisciplinary Digital Publishing Institute</subfield><subfield code="c">2020</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 electronic resource (390 p.)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">There is talk of an upcoming antibiotic armageddon, with untreatable post-operative infections, and similarly untreatable complications after chemotherapy. Indeed, the now famous “O’Neill Report” (https://amr-review.org/) suggests that, by 2050, more people might die from antibiotic-resistant bacterial infections than from cancer. While we are still learning all the subtle drivers of antibiotic resistance, it seems increasingly clear that we need to take a “one health” approach, curtailing the use of antibiotics in both human and veterinary medicine. However, there are no new classes of antibiotics on our horizon. Maybe something that has been around “forever” can come to our rescue—bacteriophages! Nevertheless, it is also necessary to do things differently, and use these new antimicrobials appropriately. Therefore, an in-depth study of bacteriophage biology and case-by-case applications might be required. Whilst by no means comprehensive, this book does cover some of the many topics related to bacteriophages as antimicrobials, including their use in human therapy and aquaculture. It also explores the potential use of phage endolysins as substitutes of antibiotics in two sectors where there is an urgent need—human therapy and the agro-food industry. Last but not least, there is an excellent perspective article on phage therapy implementation.</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">English</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Medicine</subfield><subfield code="2">bicssc</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">bacteriophages</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">dairy industry</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">pathogens</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">lactic acid bacteria</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">fermentation failure</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">biofilms</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">antimicrobial resistance</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">antimicrobials</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">lysins</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">horizontal gene transfer, transduction</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">biofilm</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">phage therapy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">resistance</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">bacteriophage</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">models</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">agent based</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">mass action</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">bacterial phage resistance</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">regression modeling</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">MRSA</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Clostridium difficile</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Clostridium difficile infection</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">microbiome</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">in vitro fermentation model</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">marine vibrios</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">biological control</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">aquaculture</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">interactions</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">vibriosis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Aeromonas hydrophila</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Motile Aeromonas Septicemia</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">MAS</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">multiple-antibiotic-resistance</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">striped catfish (Pangasianodon hypophthalmus)</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">endolysin</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">antibiotics</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">one health</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">protein engineering</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Aeromonas salmonicida</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">furunculosis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">phage-resistant mutants</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">proteins</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">infrared spectroscopy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">lysin</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">lytic enzyme</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">peptidoglycan hydrolase</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">antimicrobial</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">antibacterial</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">antibiotic resistance</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">bacteriophage therapy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Nagoya Protocol</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">CRISPR CAS</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">phage isolation</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">phage resistance</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Staphylococcus</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Kayvirus</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Vibrio anguillarum</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">fish larvae</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">challenge trials</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">phage display</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">enzybiotics</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Bacteriophages</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">diabetic foot ulcer</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">osteomyelitis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Staphylococcus aureus</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Antibiotic-resistant bacteria</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">lysogenic conversion</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">prophage induction</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">read recruitment</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">shiga toxin</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">American Foulbrood</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">phage</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Paenibacillus larvae</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Brevibacillus laterosporus</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">treatment</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">safety</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">bystander phage therapy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Mycobacterium smegmatis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">mycobacteriophages</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">directed evolution</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">PlyC CHAP</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">protein net charge</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">CBD-independent</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">FoldX</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">STEC-specific bacteriophage</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">whole genome sequencing</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">STEC O145 strains</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">antimicrobial agent</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Pseudomonas aeruginosa</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">dual-species</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">antibiotic</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">synergy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">simultaneous</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">sequential</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">microbiome therapy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">evolution</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-03943-404-7</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-03943-405-5</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Fernández, Lucía</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Suárez, Pilar García</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Fernández, Lucía</subfield><subfield code="4">oth</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2024-01-23 00:50:11 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2022-04-04 09:22:53 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&amp;portfolio_pid=5338233260004498&amp;Force_direct=true</subfield><subfield code="Z">5338233260004498</subfield><subfield code="b">Available</subfield><subfield code="8">5338233260004498</subfield></datafield></record></collection>